Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.39M Sell
75,000
-25,000
-25% -$453K 0.91% 41
2017
Q4
$1.94M Sell
100,000
-40,000
-29% -$677K 1.26% 29
2017
Q3
$2.78M Sell
140,000
-35,000
-20% -$559K 1.52% 29
2017
Q2
$2.77M Hold
175,000
1.57% 27
2017
Q1
$4.27M Buy
175,000
+25,000
+17% +$638K 2.11% 14
2016
Q4
$3.17M Sell
150,000
-250,000
-63% -$4.27M 1.89% 19
2016
Q3
$6.7M Buy
400,000
+200,000
+100% +$1.9M 1.19% 28
2016
Q2
$1.6M Buy
+200,000
New +$1.75M 0.65% 50

Other funds holding MRUS

Iguana Healthcare Management's MRUS Position: Q1 2018 in Review

Iguana Healthcare Management reduced its Merus (MRUS) stake by 25% in Q1 2018, selling an estimated $453K and leaving 75,000 shares worth $1.39M. The position accounts for 0.91% of the portfolio, ranked #41.

Iguana Healthcare Management first reported a position in MRUS in Q2 2016 and has held it in 8 quarters since. The position peaked at $6.7M in Q3 2016. 20 funds tracked by Wall St. Rank hold MRUS as of Q1 2018.

  • Iguana Healthcare Management held 75,000 shares of Merus worth $1.39M as of Q1 2018.
  • Iguana Healthcare Management sold 25,000 Merus shares in Q1 2018, an estimated $453K.
  • Merus made up 0.91% of Iguana Healthcare Management's portfolio in Q1 2018, its #41 holding.
  • Iguana Healthcare Management first reported a position in Merus in Q2 2016 and has held it in 8 quarters since.
  • Iguana Healthcare Management's Merus position peaked at $6.7M in Q3 2016.
  • 20 funds tracked by Wall St. Rank held Merus as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.